Topic
- addiction
- adrenal cancer
- alcohol
- Alzheimer's
- asthma
- biobank
- breast cancer
- cancer
- cessation
- chemotherapy
- colorectal cancer
- diabetes
- disease management
- gastrointestinal illness
- genetics
- health insurance
- hearing loss
- hearing protection
- heart disease
- HIV / AIDS
- HPV
- injury
- liver
- lung cancer
- medical history
- medication adherence
- mental health
- nutrition
- obesity
- oral health
- organ donation
- organ quality
- organ transplant
- other
- ovarian cancer
- physical activity
- post-treatment
- prevention
- prostate cancer
- quality of life
- recurrence
- screening
- skin cancer
- sleep safety
- smoking
- STD
- stroke
- survivorship
- symptoms
- treatment
- vaccination
- weight loss
Audience
- adolescents
- adults
- African Americans
- alumni
- caregivers
- children
- college students
- farmers
- fraternities and sororities
- girls
- health care providers
- high risk
- HMO members
- Latinos
- LGBT
- Medicare enrollees
- men
- mothers
- non-smokers
- older adults
- parents
- patients
- people living with HIV/AIDS
- research volunteers
- school age children
- smokers
- survivors
- transplant recipients
- transplant waiting list
- underserved
- veterans
- women
- young adults
Setting
Technology
Journal:
Journal of Womens Health (Larchmt)
Date: 11/09/2010
Feasibility of using maternal cancer screening visits to identify adolescent girls eligible for human papillomavirus vaccination
Carlos, R. C., A. F. Dempsey, et al. (2010). "Feasibility of using maternal cancer screening visits to identify adolescent girls eligible for human papillomavirus vaccination." J Womens Health (Larchmt) 19(12): 2271-2275.
Abstract
PURPOSE: Breast or cervical cancer screening visits may present an opportunity to motivate mothers to have their daughters vaccinated against human papillomavirus (HPV). In preparation for a future intervention study, we sought to establish the feasibility of using these visits to identify women with at least one daughter in the appropriate age range for adolescent HPV vaccination. METHODS: We conducted a cross-sectional mailed survey of women who had received breast or cervical cancer screening within the 6-18 months before the survey. The study was conducted at two diverse institutions: one serving a mostly black (54.1%) urban inner-city population and another serving a mostly white (87.5%) suburban population. RESULTS: Our overall response rate was 28% (n = 556) in the urban site and 38% (n = 381) in the suburban site. In the urban site, the proportions of mothers completing mammography or Pap smear visits with HPV vaccine-eligible daughters were 23% and 24%, respectively. In the suburban site, the proportions of mothers completing mammography or Pap smear with at least one vaccine-eligible daughter were 41% and 26%, respectively. CONCLUSIONS: Women who undergo breast or cervical cancer screening in the two different demographic groups evaluated have at least one adolescent daughter at the appropriate age for HPV vaccination. An important implication of this finding in adolescent daughters of urban mothers is the potential use of maternal breast or cervical cancer screening encounters to target a potentially undervaccinated group.
Associated People: Ruth C. Carlos, MD, Vanessa K Dalton, MD, MPH, Amanda F. Dempsey, MD, PhD, MPH, Kenneth A. Resnicow, PhD, Mack T. Ruffin IV, MD, MPH
Associated Projects: Healthy Moms/Healthy Daughters
